• TRM (USD/COP)COP 3,235.59 +1.65% +COP 52.60Colombia's official exchange rate (Financial Superintendence), valid Nov 4 to Nov 4
  • EuroCOP 3,617.08 +1.72% +COP 61.02Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote
  • Mexican pesoCOP 173.98 +3.35% +COP 5.64Reference: TRM crossed with the European Central Bank rate of Nov 3; not the market quote

L'Oréal ties part of its skincare sales momentum to the GLP-1 drug boom

FinanceInternationalBBC30 s readAI summary
Image: BBC

L'Oréal, the world's largest cosmetics company, says the boom in GLP-1 weight-loss drugs, known by brands such as Ozempic, Wegovy or Mounjaro, is boosting beauty and skincare sales. CEO Nicolas Hieronimus said on an investor call that GLP-1 use is "a very important phenomenon" for the company. L'Oréal reported a 7.7% rise in third-quarter sales, above analysts' expectations.

In 30 seconds

  • L'Oréal says GLP-1 use is affecting beauty consumption, particularly skincare.
  • Its third-quarter sales rose 7.7% and beat analysts' expectations.
  • Brands such as SkinCeuticals and Kiehl's have products aimed at countering skin sagging linked to rapid weight loss.
Read the full story at BBC

IASummary generated by artificial intelligence from a story by BBC. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading